Does a SCN1A gene mutation confer earlier age of onset of febrile seizures in GEFS+?

22Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

SCN1A is the most clinically relevant epilepsy gene and is associated with generalized epilepsy and febrile seizure plus (GEFS+) and Dravet syndrome. We postulated that earlier onset of febrile seizures in the febrile seizure (FS) and febrile seizure plus (FS+) phenotypes may occur in the presence of a SCN1A mutation. This was because of the age-related onset of Dravet syndrome, which typically begins in the first year of life. We found that patients with FS and FS+ with SCN1A mutations had earlier median onset of febrile seizures compared to the population median. Patients with GABRG2 mutations had a similar early onset in contrast to patients with SCN1B mutations where onset was later. This study is the first to demonstrate that a specific genetic abnormality directly influences the FS and FS+ phenotype in terms of age of onset. © 2009 International League Against Epilepsy.

Cite

CITATION STYLE

APA

Sijben, A. E. J., Sithinamsuwan, P., Radhakrishnan, A., Badawy, R. A. B., Dibbens, L., Mazarib, A., … Scheffer, I. E. (2009). Does a SCN1A gene mutation confer earlier age of onset of febrile seizures in GEFS+? Epilepsia, 50(4), 953–956. https://doi.org/10.1111/j.1528-1167.2009.02023.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free